Literature DB >> 21658389

miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.

Sheng Tan1, Rui Li, Keshuo Ding, Peter E Lobie, Tao Zhu.   

Abstract

Metastasis is the leading cause of death in patients with hepatocellular carcinoma (HCC) and microRNAs have been implicated to influence this process. Emerging evidence indicates that miR-198 is down-regulated in HCC compared to normal liver parenchyma, but the functional roles of miR-198 in HCC cells remains unexplored. Herein, we show that miR-198 directly targets c-MET via its 3'UTR. Forced expression of miR-198 decreased c-MET expression at both mRNA and protein levels and consequently diminished HGF induced phosphorylation of p44/42 MAPK in HCC cells. Forced expression of miR-198 inhibited HGF promotion of HCC cell migration and invasion in a c-MET dependent manner. In conclusion, we have identified miR-198 as a novel suppressor of HCC cell invasion by negative regulation of the HGF/c-MET pathway.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658389     DOI: 10.1016/j.febslet.2011.05.042

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  50 in total

1.  Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells.

Authors:  Sheng Tan; Keshuo Ding; Qing-Yun Chong; Junsong Zhao; Yuan Liu; Yunying Shao; Yuanyuan Zhang; Qing Yu; Zirui Xiong; Weijie Zhang; Min Zhang; Gaopeng Li; Xiaoni Li; Xiangjun Kong; Akhlaq Ahmad; Zhengsheng Wu; Qiang Wu; Xiaodong Zhao; Peter E Lobie; Tao Zhu
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

2.  C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.

Authors:  Hang Li; Bo Zhang; Meng Ding; Shang Lu; Hui Zhou; Dajun Sun; Gang Wu; Xianfeng Gan
Journal:  Hepatol Int       Date:  2019-05-08       Impact factor: 6.047

3.  MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.

Authors:  Er Nie; Xin Jin; Weining Wu; Tianfu Yu; Xu Zhou; Zhumei Shi; Junxia Zhang; Ning Liu; Yongping You
Journal:  J Neurooncol       Date:  2017-04-19       Impact factor: 4.130

Review 4.  Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

Authors:  Joseph George; Tushar Patel
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

5.  miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.

Authors:  X Zhou; C Z Zhang; S-X Lu; G G Chen; L-Z Li; L-L Liu; C Yi; J Fu; W Hu; J-M Wen; J-P Yun
Journal:  Oncogene       Date:  2014-03-17       Impact factor: 9.867

6.  Investigation of microRNA expression changes in HepG2 cell line in presence of URG4/URGCP and in absence of URG4/URGCP suppressed by RNA interference.

Authors:  Yavuz Dodurga; G Nilufer Yonguc; Cigir Biray Avci; Gulseren Bagci; Cumhur Gunduz; N Lale Satiroglu-Tufan
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

Review 7.  Role of circulatory microRNAs in the pathogenesis of hepatitis C virus.

Authors:  Iqra Almas; Samia Afzal; Muhammad Idrees; Muhammad Usman Ashraf; Iram Amin; Muhammad Shahid; Khadija Zahid; Sadia Zahid
Journal:  Virusdisease       Date:  2017-11-27

8.  MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met.

Authors:  Xin Xu; Hong Chen; Yiwei Lin; Zhenghui Hu; Yeqing Mao; Jian Wu; Xianglai Xu; Yi Zhu; Shiqi Li; Xiangyi Zheng; Liping Xie
Journal:  Mol Cells       Date:  2013-05-30       Impact factor: 5.034

9.  MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met.

Authors:  Yue Gao; Fan Zeng; Jia-Yan Wu; Hai-Yu Li; Jian-Jun Fan; Li Mai; Ji Zhang; Dong-Mei Ma; Yun Li; Fang-zhou Song
Journal:  Tumour Biol       Date:  2014-12-10

10.  Evaluation of Apoptotic Marker Bcl2, CD4+, Human Hepatocyte Growth Factor and Metalloproteinase-9 as Tumor Markers for Patients with Hepatocellular Carcinoma.

Authors:  Eman R Youness; Mohamed El Nemr; F S Oraby; Nadia M Ahmed; Mohamed A Moghni; Hanan F Aly; Hanaa H Ahmed
Journal:  Indian J Clin Biochem       Date:  2013-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.